Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. Immunology. 2011, Aug; 133(4): 426-433.
  1. 2.   CpG DNA as a vaccine adjuvant
  2. Bode, C.; Zhao, G.; Steinhagen, F.; Kinjo, T.; Klinman, D. M.
  3. Expert Review of Vaccines. 2011, Apr; 10(4): 499-511.
  1. 3.   Gene Expression Profiles in a Rabbit Model of Systemic Lupus Erythematosus Autoantibody Production
  2. Rai, G.; Ray, S.; Milton, J.; Yang, J.; Ren, P.; Lempicki, R.; Mage, R. G.
  3. Journal of Immunology. 2010, Oct; 185(7): 4446-4456.
  1. 4.   FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
  2. Klinman, D. M.; Klaschik, S.; Tross, D.; Shirota, H.; Steinhagen, F.
  3. Vaccine. 2010, Apr; 28(16): 2801-2805.
  1. 5.   Association of Y chromosome haplogroup I with HIV progression, and HAART outcome
  2. Sezgin, E.; Lind, J. M.; Shrestha, S.; Hendrickson, S.; Goedert, J. J.; Donfield, S.; Kirk, G. D.; Phair, J. P.; Troyer, J. L.; O'Brien, S. J.; Smith, M. W.
  3. Human Genetics. 2009 125(3): 281-294.
  1. 6.   Development of regulatory T cells requires IL-7R alpha stimulation by IL-7 or TSLP
  2. Mazzucchelli, R.; Hixon, J. A.; Spolski, R.; Chen, X.; Li, W. Q.; Hall, V. L.; Willette-Brown, J.; Hurwitz, A. A.; Leonard, W. J.; Durum, S. K.
  3. Blood. 2008, Oct 15; 112(8): 3283-3292.
  1. 7.   The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
  2. Wuest, T. Y.; Willette-Brown, J.; Durum, S. K.; Hurwitz, A. A.
  3. Journal of Leukocyte Biology. 2008 84(4): 973-980.
  1. 8.   HLA polymorphisms in African Americans with idiopathic inflammatory myopathy - Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies
  2. O'Hanlon, T. P.; Rider, L. G.; Mamyrova, G.; Targoff, I. N.; Arnett, F. C.; Reveille, J. D.; Carrington, M.; Gao, X. J.; Oddis, C. V.; Morel, P. A.; Malley, J. D.; Malley, K.; Shamim, E. A.; Chanock, S. J.; Foster, C. B.; Bunch, T.; Reed, A. M.; Love, L. A.; Miller, F. W.
  3. Arthritis and Rheumatism. 2006, Nov; 54(11): 3670-3681.
  1. 9.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 10.   Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection
  2. Estes, J. D.; Li, Q. S.; Reynolds, M. R.; Wietgrefe, S.; Duan, L. J.; Schacker, T.; Picker, L. J.; Watkins, D. I.; Lifson, J. D.; Reilly, C.; Carlis, J.; Haase, A. T.
  3. Journal of Infectious Diseases. 2006, Mar; 193(5): 703-712.
  1. 11.   Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies - Distinct HLA-A -B, -Cw,-DRB1, and-DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies
  2. O'Hanlon, T. P.; Carrick, D. M.; Targoff, I. N.; Arnett, F. C.; Reveille, J. D.; Carrington, M.; Gao, A. J.; Oddis, C. V.; Morel, P. A.; Malley, J. D.; Malley, K.; Shamim, E. A.; Rider, L. G.; Chanock, S. J.; Foster, C. B.; Bunch, T.; Blackshear, P. J.; Plotz, P. H.; Love, L. A.; Miller, F. W.
  3. Medicine. 2006, Mar; 85(2): 111-127.
  1. 12.   TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer
  2. Cretney, E.; Shanker, A.; Yagita, H.; Smyth, M. J.; Sayers, T. J.
  3. Immunology and Cell Biology. 2006, FEB; 84(1): 87-98.
  1. 13.   Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies - Distinct HLA-A, -B, -Cw,-DRB1 and -DQA1 allelic profiles and motifs define clinicopothologic groups in Caucasians
  2. O'Hanlon, T. P.; Carrick, D. M.; Arnett, F. C.; Reveille, J. D.; Carrington, M.; Gao, X. J.; Oddis, C. V.; Morel, P. A.; Malley, J. D.; Malley, K.; Dreyfuss, J.; Shamim, E. A.; Rider, L. G.; Chanock, S. J.; Foster, C. B.; Bunch, T.; Plotz, P. H.; Love, L. A.; Miller, F. W.
  3. Medicine. 2005, NOV; 84(6): 338-349.
  1. 14.   Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
  2. Carrington, M.; Wang, S.; Martin, M. P.; Gao, X. J.; Schiffman, M.; Cheng, J.; Herrero, R.; Rodriguez, A. C.; Kurman, R.; Mortel, R.; Schwartz, P.; Glass, A.; Hildesheim, A.
  3. Journal of Experimental Medicine. 2005, APR 4; 201(7): 1069-1075.
  1. 15.   A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma
  2. Brown, E. E.; Fallin, M. D.; Goedert, J. J.; Chen, R.; Whitby, D.; Foster, C. B.; Lauria, C.; Alberg, A. J.; Messina, A.; Montella, M.; Rezza, G.; Vitale, F.; Chanock, S. J.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, MAR; 14(3): 633-637.
  1. 16.   Co-operative functions between nuclear factors NF kappa B and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells
  2. Xiao, W. H.; Hodge, D. R.; Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Farrar, W. L.
  3. Prostate. 2004, DEC 1; 61(4): 354-370.
  1. 17.   Cutting edge: Heterozygote advantage in autoimmune disease: Hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis
  2. Nelson, G. W.; Martin, M. P.; Gladman, D.; Wade, J.; Trowsdale, J.; Carrington, M.
  3. Journal of Immunology. 2004, OCT 1; 173(7): 4273-4276.
  1. 18.   Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection
  2. Thio, C. L.; Mosbruger, T. L.; Kaslow, R. A.; Karp, C. L.; Strathdee, S. A.; Vlahov, D.; O'Brien, S. J.; Astemborski, J.; Thomas, D. L.
  3. Journal of Virology. 2004, OCT; 78(20): 11258-11262.
  1. 19.   Effects of IL-7 and dexamethasone: Induction of CD25, the high affinity IL-2 receptor, on human CD4(+) cells
  2. Chung, I. Y.; Dong, H. F.; Zhang, X.; Hassanein, N. M. A.; Howard, O. M. Z.; Oppenheim, J. J.; Chen, X.
  3. Cellular Immunology. 2004, NOV-DEC; 232(1-2): 57-63.
  1. 20.   Renal transplant patients show variations in their self- reactive repertoires: a serial study
  2. Portugal, K.; Dozmorov, I.; Sidorov, I.; Marrero, I.; Fonseca, J. A.; Spadafora-Ferreira, M.; Kalil, J.; Coelho, V.
  3. International Immunology. 2001 13(6): 747-755.
  1. 21.   Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells
  2. O'Laughlin-Bunner, B.; Radosevic, N.; Taylor, M. L.; Shivakrupa, DeBerry, C.; Metcalfe, D. D.; Zhou, M. J.; Lowell, C.; Linnekin, D.
  3. Blood. 2001 98(2): 343-350.
  1. 22.   Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: Identification and characterization of haplotypes shared by affected members of 101 multiple-case families
  2. Vorechovsky, I.; Cullen, M.; Carrington, M.; Hammarstrom, L.; Webster, A. D. B.
  3. Journal of Immunology. 2000 164(8): 4408-4416.
  1. 23.   Positive selection of natural autoreactive B cells
  2. Hayakawa, K.; Asano, M.; Shinton, S. A.; Gui, M.; Allman, D.; Stewart, C. L.; Silver, J.; Hardy, R. R.
  3. Science. 1999 285(5424): 113-116.
  1. 24.   Lyn Associates With the Juxtamembrane Region of C-Kit and Is Activated By Stem Cell Factor in Hematopoietic Cell Lines and Normal Progenitor Cells
  2. Linnekin, D.; Deberry, C. S.; Mou, S.
  3. Journal of Biological Chemistry. 1997 272(43): 27450-27455.
  1. 25.   Critical Roles For the Bcl-3 Oncoprotein in T Cell-Mediated Immunity, Splenic Microarchitecture, and Germinal Center Reactions
  2. Franzoso, G.; Carlson, L.; Schartonkersten, T.; Shores, E. W.; Epstein, S.; Grinberg, A.; Tran, T.; Shacter, E.; Leonardi, A.; Anver, M.; Love, P.; Sher, A.; Siebenlist, U.
  3. Immunity. 1997 6(4): 479-490.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel